Hangzhou, Zhejiang province-based cancer screening biotech company New Horizon Health announced a strategic partnership on Monday with Hong Kong-based Prenetics Group Ltd to launch in Hong Kong its ColoClear, a non-invasive stool-based test for colorectal cancer, as a first step to venture in markets beyond Chinese mainland.